These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 7898728)
1. Valproate as a cause of hyperammonemia in heterozygotes with ornithine-transcarbamylase deficiency. Leão M Neurology; 1995 Mar; 45(3 Pt 1):593-4. PubMed ID: 7898728 [No Abstract] [Full Text] [Related]
2. Heterozygote ornithine transcarbamylase deficiency presenting as symptomatic hyperammonemia during initiation of valproate therapy. Honeycutt D; Callahan K; Rutledge L; Evans B Neurology; 1992 Mar; 42(3 Pt 1):666-8. PubMed ID: 1549234 [TBL] [Abstract][Full Text] [Related]
3. Valproate-induced lethal hyperammonaemic coma in a carrier of ornithine carbamoyltransferase deficiency. Tokatli A; Coşkun T; Cataltepe S; Ozalp I J Inherit Metab Dis; 1991; 14(5):836-7. PubMed ID: 1779634 [No Abstract] [Full Text] [Related]
4. Valproate-induced hyperammonemia - uncovering an underlying inherited metabolic disorder: a case report. Mehta S; Tayabali S; Lachmann R J Med Case Rep; 2018 May; 12(1):134. PubMed ID: 29769109 [TBL] [Abstract][Full Text] [Related]
5. [Hyperammonaemic coma after valproate therapy as adult onset of ornithine transcarbamylase deficiency]. Padilla Mde L; Miguélez M; Riverola A; Bueno J Med Clin (Barc); 2002 Feb; 118(5):199. PubMed ID: 11852003 [No Abstract] [Full Text] [Related]
6. Hyperammonaemic encephalopathy after initiation of valproate therapy in unrecognised ornithine transcarbamylase deficiency. Oechsner M; Steen C; Stürenburg HJ; Kohlschütter A J Neurol Neurosurg Psychiatry; 1998 May; 64(5):680-2. PubMed ID: 9598692 [TBL] [Abstract][Full Text] [Related]
7. Sodium valproate and ornithine carbamyl transferase deficiency. Tripp JH; Hargreaves T; Anthony PP; Searle JF; Miller P; Leonard JV; Patrick AD; Oberholzer VG Lancet; 1981 May; 1(8230):1165-6. PubMed ID: 6112522 [No Abstract] [Full Text] [Related]
8. Study of enzyme defect in a case of ornithine transcarbamylase deficiency. Qureshi IA; Letarte J; Quellet R Diabete Metab; 1978 Dec; 4(4):239-41. PubMed ID: 729890 [TBL] [Abstract][Full Text] [Related]
10. [A new family with mutation of the structural gene of human ornithine carbamoyltransferase]. Stoll C; Bieth R; Dreyfus J; Flori E; Lutz P; Levy JM Arch Fr Pediatr; 1978 May; 35(5):512-8. PubMed ID: 678030 [TBL] [Abstract][Full Text] [Related]
11. Prenatal counseling in heterozygotes for ornithine transcarbamylase deficiency. Fries MH; Kuller JA; Jurecki E; Packman S Clin Pediatr (Phila); 1994 Sep; 33(9):525-9. PubMed ID: 8001320 [TBL] [Abstract][Full Text] [Related]
13. Fatal cerebral edema from late-onset ornithine transcarbamylase deficiency in a juvenile male patient receiving valproic acid. Thakur V; Rupar CA; Ramsay DA; Singh R; Fraser DD Pediatr Crit Care Med; 2006 May; 7(3):273-6. PubMed ID: 16575347 [TBL] [Abstract][Full Text] [Related]
14. Hyperammonemic coma due to parenteral nutrition in a woman with heterozygous ornithine transcarbamylase deficiency. Felig DM; Brusilow SW; Boyer JL Gastroenterology; 1995 Jul; 109(1):282-4. PubMed ID: 7797025 [TBL] [Abstract][Full Text] [Related]
15. [Anesthetic management of a patient with ornithine transcarbamylase deficiency associated with hyperammonemia (author's transl)]. Yasuoka M; Kokubo S Masui; 1978 May; 27(5):526-32. PubMed ID: 660908 [No Abstract] [Full Text] [Related]
16. Ornithine transcarbamylase deficiency: adult onset of severe symptoms. Gilchrist JM; Coleman RA Ann Intern Med; 1987 Apr; 106(4):556-8. PubMed ID: 3826955 [TBL] [Abstract][Full Text] [Related]
17. Congenital hyperammonemia: symptomatic carrier girl patient and her asymptomatic heterozygous mother for ornithine transcarbamylase (OTC) deficiency: specific enzyme diagnostic and kinetic investigations for the detection of heterozygous genostatus. László A; Karsai T; Várkonyi A Acta Paediatr Hung; 1991; 31(3):291-7. PubMed ID: 1742044 [TBL] [Abstract][Full Text] [Related]